Strategies for the development of cell lines for ex vivo gene therapy in the central nervous system
Review
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Disorders of the central nervous system (CNS) as a result of trauma or ischemic or neurodegenerative processes still pose a challenge for modern medicine. Due to the complexity of the CNS, and in spite of the advances in the knowledge of its anatomy, pharmacology, and molecular and cellular biology, treatments for these diseases are still limited. The development of cell lines as a source for transplantation into the damaged CNS (cell therapy), and more recently their genetic modification to favor the expression and delivery of molecules with therapeutic potential (ex vivo gene therapy), are some of the techniques used in search of novel restorative strategies. This article reviews the different approaches that have been used and perfected during the last decade to generate cell lines and their use in experimental models of neuronal damage, and evaluates the prospects of applying these methods to treat CNS disorders. © 2011 Cognizant Comm. Corp.
publication date
published in
Research
keywords
-
Cell lines; Central nervous system disorders; Development strategies; Ex vivo gene therapy adenovirus vector; dihydrofolate reductase; DNA fragment; elongation factor 1alpha; lentivirus vector; neuron specific enolase; phosphoglycerate kinase; platelet derived growth factor B; retrovirus vector; small interfering RNA; synapsin I; Adeno associated virus; adrenal medulla tumor; cell differentiation; central nervous system tumor; Cytomegalovirus; electroporation; embryonic stem cell; ex vivo gene transfer; gene expression; gene targeting; glioma; hematopoietic stem cell; Herpes simplex virus; human; neural stem cell; neuroblastoma; nonhuman; plasmid; pluripotent stem cell; priority journal; review; RNA interference; Simian virus 40; teratocarcinoma; therapy effect; transposon; tumor cell; Cell Line; Central Nervous System Diseases; Gene Therapy; Gene Transfer Techniques; Genetic Vectors; Humans; Neural Stem Cells; Nuclear Reprogramming; RNA, Small Interfering
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue